0
ARTICLE |

Autoimmunity and Pregnancy Loss FREE

D. Ware Branch, MD
[+] Author Affiliations

Reprint requests to Department of Obstetrics and Gynecology, University of Utah School of Medicine, 50 N Medical Dr, Salt Lake City, UT 84132 (Dr Branch).


JAMA. 1990;264(11):1453-1454. doi:10.1001/jama.1990.03450110099036
Text Size: A A A
Published online

The spontaneous loss of a clinically recognized pregnancy is the most common complication of human gestation and is a significant emotional disappointment for the involved couple. Recurrent pregnancy loss (traditionally defined as three consecutive losses) occurs in 0.5% to 1% of women, an incidence equal to or exceeding that of most major medical problems. Genetic, anatomic, hormonal, and infectious factors have each been implicated as causing some spontaneous abortion, but even when taken together they do not explain the majority of losses. Within the last 10 years several maternal autoimmune conditions have been linked to pregnancy loss. Although these autoimmune conditions do not appear to explain a large proportion of losses, they are as important numerically as uterine malformations and parental chromosome abnormalities.

A few maternal autoimmune conditions cause pregnancy loss through the transplacental passage of maternal autoantibodies that act on the fetus through classic autoantibody-mediated mechanisms. The best example

REFERENCES

Carter JB, Blieden LC, Edwards JE.  Congenital heart block: anatomic correlations and review of the literature . Arch Pathol. 1974;;97:51-57.
Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP.  Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block . NEngl JMed. 1983;;309:209-212.
Taylor PV, Scott JS, Gerlis LM, Esscher E, Scott O.  Maternal antibodies against fetal cardiac antigens in congenital complete heart block . N Engl J Med. 1986;;315:667-672.
Lee LA, Harmon CE, Huff JC, Norris DA, Weston WL.  The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin . J Clin Invest Dermatol. 1985;;85:143-146.
Pekonen F, Teramo K, Makinen T, Ikonee E, Osterlund K, Lamberg BA.  Prenatal diagnosis and treatment of fetal thyrotoxicosis . Am J Obstet Gynecol. 1984;;150:893-894.
Davis LE, Lucas MJ, Hankins GDV, Roark ML, Cunningham FG.  Thyrotoxicosis complicating pregnancy . Am J Obstet Gynecol. 1989;;160:63-70.
Munro DS, Dirmikis SM, Humphries H, Smith T, Broadhead GD.  The role of thyroid stimulating immunoglobulins of Graves' disease in neonatal thyrotoxicosis . Br J Obstet Gynaecol. 1978;;85:837-843.
Laros RK, Sweet RL.  Management of idiopathic thrombocytopenic purpura during pregnancy . Am J Obstet Gynecol. 1975;;122:182-190.
Harris EN.  Syndrome of the black swan . Br J Rheumatol. 1987;;26:324-326.
Branch DW, Scott JR.  Clinical implications of antiphospholipid antibodies: the Utah experience . In: Harris EN, Exner T, Hughes GRV, Asherson R, eds. Phospholipid-binding Antibodies . Boca Raton, Fla: CRC Press. In press.
DeWolf F, Carreras LO, Moerman P, et al.  Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant . Am J Obstet Gynecol. 1982;;142:829-834.
Branch DW, Dudley DJ, Mitchell MD, et al.  IgG fractions from patients with antiphospholipid antibodies cause fetal death in Balb/C mice: a model for autoimmune fetal loss . Am J Obstet Gynecol. 1990;;163:210-216.
Sheppard BL, Bonnar J.  An ultrastructural study of the utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation . Br J Obstet Gynaecol. 1981;;88:695-705.
Stagnaro-Green A, Roman SH, Cobin RH, El-Harazy E, Alvarez-Marfany M, Davies TF.  Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies . JAMA . 1990;;264:1422-1425.
Ramsey I.  Postpartum thyroiditis—an underdiagnosed disease . Br J Obstet Gynaecol. 1986;;93:1121-1123.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Carter JB, Blieden LC, Edwards JE.  Congenital heart block: anatomic correlations and review of the literature . Arch Pathol. 1974;;97:51-57.
Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP.  Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block . NEngl JMed. 1983;;309:209-212.
Taylor PV, Scott JS, Gerlis LM, Esscher E, Scott O.  Maternal antibodies against fetal cardiac antigens in congenital complete heart block . N Engl J Med. 1986;;315:667-672.
Lee LA, Harmon CE, Huff JC, Norris DA, Weston WL.  The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin . J Clin Invest Dermatol. 1985;;85:143-146.
Pekonen F, Teramo K, Makinen T, Ikonee E, Osterlund K, Lamberg BA.  Prenatal diagnosis and treatment of fetal thyrotoxicosis . Am J Obstet Gynecol. 1984;;150:893-894.
Davis LE, Lucas MJ, Hankins GDV, Roark ML, Cunningham FG.  Thyrotoxicosis complicating pregnancy . Am J Obstet Gynecol. 1989;;160:63-70.
Munro DS, Dirmikis SM, Humphries H, Smith T, Broadhead GD.  The role of thyroid stimulating immunoglobulins of Graves' disease in neonatal thyrotoxicosis . Br J Obstet Gynaecol. 1978;;85:837-843.
Laros RK, Sweet RL.  Management of idiopathic thrombocytopenic purpura during pregnancy . Am J Obstet Gynecol. 1975;;122:182-190.
Harris EN.  Syndrome of the black swan . Br J Rheumatol. 1987;;26:324-326.
Branch DW, Scott JR.  Clinical implications of antiphospholipid antibodies: the Utah experience . In: Harris EN, Exner T, Hughes GRV, Asherson R, eds. Phospholipid-binding Antibodies . Boca Raton, Fla: CRC Press. In press.
DeWolf F, Carreras LO, Moerman P, et al.  Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant . Am J Obstet Gynecol. 1982;;142:829-834.
Branch DW, Dudley DJ, Mitchell MD, et al.  IgG fractions from patients with antiphospholipid antibodies cause fetal death in Balb/C mice: a model for autoimmune fetal loss . Am J Obstet Gynecol. 1990;;163:210-216.
Sheppard BL, Bonnar J.  An ultrastructural study of the utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation . Br J Obstet Gynaecol. 1981;;88:695-705.
Stagnaro-Green A, Roman SH, Cobin RH, El-Harazy E, Alvarez-Marfany M, Davies TF.  Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies . JAMA . 1990;;264:1422-1425.
Ramsey I.  Postpartum thyroiditis—an underdiagnosed disease . Br J Obstet Gynaecol. 1986;;93:1121-1123.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.